{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:57:35Z","timestamp":1780991855269,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10072-026-09069-2","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T07:24:57Z","timestamp":1779693897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of modified Erasmus Guillaiun Barre\u2019 syndrome outcome score (mEGOS) in an Italian cohort of patients: Challenges, insights and limitations"],"prefix":"10.1007","volume":"47","author":[{"given":"Marco","family":"Mazzoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ariatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Benuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Gozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Bastia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Agnoletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Marchioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Valzania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8775-0415","authenticated-orcid":false,"given":"Giuliana","family":"Galassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"9069_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C Fokke","year":"2014","unstructured":"Fokke C, van den Berg B, Drenthen J et al (2014) Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria. Brain 137:33\u201343. https:\/\/doi.org\/10.1093\/brain\/awt285","journal-title":"Brain"},{"key":"9069_CR2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/jns.12234","volume":"22","author":"Y Yamagishi","year":"2017","unstructured":"Yamagishi Y, Suzuki H, Sonoo M et al (2017) Markers for Guillain-Barr\u00e9 syndrome with poor prognosis: a multi-center study. J Peripher Nerv Syst 22:433\u2013439. https:\/\/doi.org\/10.1111\/jns.12234","journal-title":"J Peripher Nerv Syst"},{"key":"9069_CR3","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/acn3.706","volume":"6","author":"Z Islam","year":"2019","unstructured":"Islam Z, Papri N, Ara G et al (2019) Risk factors for respiratory failure in Guillain-Barr\u00e9 syndrome in Bangladesh: a prospective study. Ann Clin Transl Neurol 6:324\u2013332. https:\/\/doi.org\/10.1002\/acn3.706","journal-title":"Ann Clin Transl Neurol"},{"issue":"11","key":"9069_CR4","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","volume":"76","author":"C Walgaard","year":"2011","unstructured":"Walgaard C, Lingsma HF, Ruts L et al (2011) Early recognition of poor prognosis in Guillain-Barr\u00e9 syndrome. Neurology 76(11):968\u2013975. https:\/\/doi.org\/10.1212\/WNL.0b013e3182104407","journal-title":"Neurology"},{"key":"9069_CR5","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1212\/WNL.0000000000013139","volume":"98","author":"AY Doets","year":"2022","unstructured":"Doets AY, Lingsma HF, Walgaard C et al (2022) Predicting outcome in Guillain-Barr\u00e9 syndrome: international validation of the modified Erasmus GBS outcome score. Neurology 98:e518\u2013e532. https:\/\/doi.org\/10.1212\/WNL.0000000000013139","journal-title":"Neurology"},{"key":"9069_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/jns.12320","volume":"24","author":"CY Tan","year":"2019","unstructured":"Tan CY, Razali SNO, Goh KJ, Shahrizaila N (2019) The utility of Guillain-Barr\u00e9 syndrome prognostic models in Malaysian patients. J Peripher Nerv Syst 24:168\u2013173. https:\/\/doi.org\/10.1111\/jns.12320","journal-title":"J Peripher Nerv Syst"},{"issue":"1","key":"9069_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12883-023-03143-4","volume":"23","author":"X Di","year":"2023","unstructured":"Di X, Wang J, Li L, Liu L (2023) Establishment of a single-center-based early prognostic scoring system for Guillain-Barr\u00e9 syndrome. BMC Neurol 23(1):97. https:\/\/doi.org\/10.1186\/s12883-023-03143-4","journal-title":"BMC Neurol"},{"key":"9069_CR8","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/acn3.51627","volume":"9","author":"N Papri","year":"2022","unstructured":"Papri N, Doets AY, Mohammad QD et al (2022) Validation and adjustment of modified Erasmus GBS outcome score in Bangladesh. Ann Clin Transl Neurol 9:1264\u20131275. https:\/\/doi.org\/10.1002\/acn3.51627","journal-title":"Ann Clin Transl Neurol"},{"key":"9069_CR9","doi-asserted-by":"publisher","unstructured":"Papri N, Islam Z, Leonhard SE, et al (2021) Guillain-Barr\u00e9 syndrome in low-income and middle income countries: challenges and prospects. Nat Rev Neurol 17:285-296. https:\/\/doi.org\/10.1038\/s41582-021-00467-y","DOI":"10.1038\/s41582-021-00467-y"},{"key":"9069_CR10","doi-asserted-by":"publisher","first-page":"123588","DOI":"10.1016\/j.jns.2025.123588","volume":"475","author":"A Ariatti","year":"2025","unstructured":"Ariatti A, Mazzoli M, Bastia E et al (2025) Predictors of poor prognosis in Guillain-Barre\u2019 syndrome: a study of 22 years from a single Italian center. J Neurol Sci 475:123588. https:\/\/doi.org\/10.1016\/j.jns.2025.123588","journal-title":"J Neurol Sci"},{"key":"9069_CR11","doi-asserted-by":"publisher","first-page":"e16090","DOI":"10.1111\/ene.16090","volume":"31","author":"G Galassi","year":"2024","unstructured":"Galassi G, Mazzoli M, Ariatti A et al (2024) Predictors of respiratory failure in Guillain-Barr\u00e9 syndrome: a 22\u2009year cohort study from a single Italian centre. Eur J Neurol 31:e16090. https:\/\/doi.org\/10.1111\/ene.16090","journal-title":"Eur J Neurol"},{"issue":"8093","key":"9069_CR12","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/s0140-6736(78)92644-2","volume":"2","author":"RA Hughes","year":"1978","unstructured":"Hughes RA, Newsom-Davis JM, Perkin GD, Pierce J (1978) Controlled trial prednisolone in acute polyneuropathy. Lancet 2(8093):750\u2013753. https:\/\/doi.org\/10.1016\/s0140-6736(78)92644-2","journal-title":"Lancet"},{"issue":"11","key":"9069_CR13","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/mus.880141111","volume":"14","author":"RP Kleyweg","year":"1991","unstructured":"Kleyweg RP, van der Mech\u00e9 FG, Schmitz PI (1991) Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barr\u00e9 syndrome. Muscle Nerve 14(11):1103\u20131109. https:\/\/doi.org\/10.1002\/mus.880141111","journal-title":"Muscle Nerve"},{"issue":"6","key":"9069_CR14","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1212\/wnl.56.6.758","volume":"56","author":"RD Hadden","year":"2001","unstructured":"Hadden RD, Karch H, Hartung HP et al (2001) Preceding infections, immune factors, and outcome in Guillain\u2013Barre\u0301 syndrome. Neurology 56(6):758\u2013765. https:\/\/doi.org\/10.1212\/wnl.56.6.758","journal-title":"Neurology"},{"key":"9069_CR15","unstructured":"https:\/\/automeris.io\/WebPlotDigitizer\/. Extracting data\u2006from charts"},{"issue":"13","key":"9069_CR16","doi-asserted-by":"publisher","first-page":"856091","DOI":"10.3389\/fneur.2022.856091","volume":"29","author":"F Ginanneschi","year":"2022","unstructured":"Ginanneschi F, Giannini F, Sicurelli F et al (2022) Clinical features and outcome of the Guillain-Barre Syndrome: a single-center11-year experience. Front Neurol 29(13):856091. https:\/\/doi.org\/10.3389\/fneur.2022.856091","journal-title":"Front Neurol"},{"key":"9069_CR17","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s12028-023-01707-3","volume":"38","author":"KM Busl","year":"2023","unstructured":"Busl KM, Fried H, Muehlschlegel S et al (2023) Guidelines for Neuroprognostication in adults with Guillain-Barr\u00e9 Syndrome. Neurocrit Care 38:564\u2013583. https:\/\/doi.org\/10.1007\/s12028-023-01707-3","journal-title":"Neurocrit Care"},{"key":"9069_CR18","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1111\/ene.16073","volume":"30","author":"PA Van Doorn","year":"2023","unstructured":"Van Doorn PA, Van den Bergh PYK, Hadden RDM et al (2023) European Academy of Neurology\/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barr\u00e9 syndrome. Eur J Neurol 30:3646\u20133674. https:\/\/doi.org\/10.1111\/ene.16073","journal-title":"Eur J Neurol"},{"key":"9069_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/CND.0000000000000365","volume":"23","author":"LM Arnold","year":"2022","unstructured":"Arnold LM, Hehir MK, Tandan R, Kolb N, Waheed W (2022) Neck flexion strength as a predictor of need for intubation in Guillain-Barre syndrome. J Clin Neuromuscul Dis 23:119\u2013123. https:\/\/doi.org\/10.1097\/CND.0000000000000365","journal-title":"J Clin Neuromuscul Dis"},{"key":"9069_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12028-019-00781-w","volume":"32","author":"T Chakraborty","year":"2020","unstructured":"Chakraborty T, Kramer CL, Wijdicks EFM, Rabinstein AA (2020) Dysautonomia in Guillain-Barr\u00e9 Syndrome: prevalence, clinical spectrum, and outcomes. Neurocrit Care 32:113\u2013120. https:\/\/doi.org\/10.1007\/s12028-019-00781-w","journal-title":"Neurocrit Care"},{"key":"9069_CR21","doi-asserted-by":"publisher","first-page":"103070","DOI":"10.1016\/j.autneu.2022.103070","volume":"245","author":"L Baz\u00e1n-Rodr\u00edguez","year":"2023","unstructured":"Baz\u00e1n-Rodr\u00edguez L, Ruiz-Avalos JA, de Sar\u00e1chaga AJ et al (2023) Dysautonomia and related outcomes in Guillain-Barre syndrome. Auton Neurosci 245:103070. https:\/\/doi.org\/10.1016\/j.autneu.2022.103070","journal-title":"Auton Neurosci"},{"issue":"12","key":"9069_CR22","doi-asserted-by":"publisher","first-page":"608130","DOI":"10.3389\/fphar.2021.608130","volume":"27","author":"P Shang","year":"2021","unstructured":"Shang P, Feng J, Wu W, Zhang HL (2021) Intensive care and treatment of severe Guillain-Barr\u00e9 Syndrome. Front Pharmacol 27(12):608130. https:\/\/doi.org\/10.3389\/fphar.2021.608130","journal-title":"Front Pharmacol"},{"key":"9069_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1586\/1744666X.2016.1128829","volume":"12","author":"Y Wang","year":"2016","unstructured":"Wang Y, Zhang HL, Wu X, Zhu J (2016) Complications of Guillain-Barr\u00e9 syndrome. Expert Rev Clin Immunol 12:439\u2013448. https:\/\/doi.org\/10.1586\/1744666X.2016.1128829","journal-title":"Expert Rev Clin Immunol"},{"key":"9069_CR24","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/brain\/awy232","volume":"141","author":"AY Doets","year":"2018","unstructured":"Doets AY, Verboon C, van den Berg B et al (2018) Regional variation of Guillain-Barr\u00e9 syndrome. Brain 141:2866\u20132877. https:\/\/doi.org\/10.1093\/brain\/awy232","journal-title":"Brain"},{"key":"9069_CR25","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","volume":"15","author":"SE Leonhard","year":"2019","unstructured":"Leonhard SE, Mandarakas MR, Gondim FAA et al (2019) Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps. Nat Rev Neurol 15:671\u2013683. https:\/\/doi.org\/10.1038\/s41582-019-0250-9","journal-title":"Nat Rev Neurol"},{"key":"9069_CR26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jocn.2024.05.016","volume":"125","author":"J Kalita","year":"2024","unstructured":"Kalita J, Mahajan R, Kumar M (2024) Effect of intravenous immunoglobulin and plasmapheresis on nerve conduction parameters compared to the natural course of Guillain-Barr\u00e9 syndrome. J Clin Neurosci 125:76\u201382. https:\/\/doi.org\/10.1016\/j.jocn.2024.05.016","journal-title":"J Clin Neurosci"},{"issue":"7","key":"9069_CR27","doi-asserted-by":"publisher","first-page":"e0133520","DOI":"10.1371\/journal.pone.0133520","volume":"10","author":"G Zhang","year":"2015","unstructured":"Zhang G, Li Q, Zhang R, Wei X, Wang J, Qin X (2015) Subtypes and prognosis of Guillain-Barr\u00e9 syndrome in Southwest China. PLoS ONE 10(7):e0133520. https:\/\/doi.org\/10.1371\/journal.pone.0133520","journal-title":"PLoS ONE"},{"key":"9069_CR28","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1007\/s10072-021-05834-7","volume":"43","author":"JC L\u00f3pez-Hern\u00e1ndez","year":"2022","unstructured":"L\u00f3pez-Hern\u00e1ndez JC, Galnares-Olalde JA, Jorge de Sar\u00e1chaga A et al (2022) Very low peroneal nerve compound muscle action potential amplitude predicts poor outcome in patients with Guillain-Barr\u00e9 syndrome: a prospective cohort. Neurol Sci 43:3923\u20133928. https:\/\/doi.org\/10.1007\/s10072-021-05834-7","journal-title":"Neurol Sci"},{"key":"9069_CR29","doi-asserted-by":"publisher","unstructured":"Mart\u00edn-Aguilar L, Camps-Renom P, Lleix\u00e0 C et al (2020) Serum neurofilament light chain predicts long-term prognosis in Guillain-Barr\u00e9 syndrome patients. J Neurol Neurosurg Psychiatry jnnp-2020-323899. https:\/\/doi.org\/10.1136\/jnnp-2020-323899","DOI":"10.1136\/jnnp-2020-323899"},{"key":"9069_CR30","doi-asserted-by":"publisher","unstructured":"Thomma RCM, Luijten LWG, van Tilburg SJ et al (2025) Neurofilament light chain improves clinical prognostic models for Guillain-Barr\u00e9 syndrome. J Neurol Neurosurg Psychiatry 20:jnnp-2025-336046. https:\/\/doi.org\/10.1136\/jnnp-2025-336046","DOI":"10.1136\/jnnp-2025-336046"},{"key":"9069_CR31","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1136\/jnnp-2020-323960","volume":"91","author":"Y Yamagishi","year":"2020","unstructured":"Yamagishi Y, Kuwahara M, Suzuki H et al (2020) Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barr\u00e9 syndrome. J Neurol Neurosurg Psychiatry 91:1339\u20131342. https:\/\/doi.org\/10.1136\/jnnp-2020-323960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9069_CR32","doi-asserted-by":"publisher","first-page":"1303243","DOI":"10.3389\/fneur.2023.1303243","volume":"14","author":"G Xue","year":"2023","unstructured":"Xue G, Zhang Y, Wang R et al (2023) Construction and evaluation of a prognostic prediction model based on the mEGOS score for patients with Guillain-Barr\u00e9 syndrome. Front Neurol 14:1303243. https:\/\/doi.org\/10.3389\/fneur.2023.1303243","journal-title":"Front Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09069-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09069-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09069-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:05:39Z","timestamp":1780988739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09069-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["9069"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09069-2","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol of GBS was approved by the Institutional Ethical Committee (N\u00b0 N43\/2022.)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the co-authors (MM, AA, FB, MG, EB,VF, AM,FV) and myself Giuliana Galassi, MD have no financial disclosure and conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"520"}}